Cita APA

Novillo Villajos, A., Gaibar, M., Romero Lorca, A., Malón, D., Antón, B., Moreno, A., & Fernández Santander, A. (2023). HER2 and BARD1 Polymorphisms in Early HER2-Positive Breast Cancer Patients: Relationship with Response to Neoadjuvant Anti-HER2 Treatment.

Citación estilo Chicago

Novillo Villajos, Apolonia, María Gaibar, Alicia Romero Lorca, Diego Malón, Beatriz Antón, Amalia Moreno, y Ana Fernández Santander. HER2 and BARD1 Polymorphisms in Early HER2-Positive Breast Cancer Patients: Relationship With Response to Neoadjuvant Anti-HER2 Treatment. 2023.

Cita MLA

Novillo Villajos, Apolonia, et al. HER2 and BARD1 Polymorphisms in Early HER2-Positive Breast Cancer Patients: Relationship With Response to Neoadjuvant Anti-HER2 Treatment. 2023.